SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-23-000742
Filing Date
2023-10-03
Accepted
2023-10-03 08:01:37
Documents
14
Period of Report
2023-09-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea186204-8k_bluewater.htm   iXBRL 8-K 31675
2 CERTIFICATE OF DESIGNATIONS OF SERIES A PREFERRED STOCK ea186204ex3-1_bluewater.htm EX-3.1 52470
3 AMENDMENT TO ASSET PURCHASE AGREEMENT, DATED AS OF SEPTEMBER 29, 2023, BY AND BE ea186204ex10-1_bluewater.htm EX-10.1 15288
  Complete submission text file 0001013762-23-000742.txt   294300

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bwv-20230921.xsd EX-101.SCH 3012
5 XBRL LABEL FILE bwv-20230921_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bwv-20230921_pre.xml EX-101.PRE 22358
8 EXTRACTED XBRL INSTANCE DOCUMENT ea186204-8k_bluewater_htm.xml XML 3418
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Blue Water Biotech, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 231301582
SIC: 2834 Pharmaceutical Preparations